Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases
Journal of Medicinal Chemistry · 27.02.2025 · 68 (4) · 4908-4928
DOI: 10.1021/acs.jmedchem.4c03149 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 06.02.2025. Verfasst von Camilla Scarpellini und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University o…. Hauptthemen laut MEDLINE: Oxazoles, Ferroptosis. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universiteit Antwerpen, H2020 Marie Sklodowska-Curie Actions, Fonds Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Ferroptosis plays an important role in the occurrence and development of many diseases, including neurodegenerative diseases. Thus, ferroptosis inhibitors able to cross the blood-brain barrier may have therapeutic potential. The best ferroptosis inhibitors so far are lipophilic radical trapping antioxidants (RTAs) that block lipid peroxidation in membranes. Several generations of ferrostatins have been synthesized, among which UAMC-3203 showed high potency in animal models with improved properties compared to ferrostatin-1. To further improve its pharmacokinetics properties, drug-likeness, and permeability, we modified UAMC-3203 by decreasing the size of the molecule and reducing its polarity by replacing the sulfonamide first by amide groups and subsequently by isosteric oxazoles. Herein, we present the design, synthesis, and biological evaluation of a novel series of oxazole RTAs with high potency, excellent oral bioavailability, and high concentrations in brain tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Medicinal Chemistry, Department of Pharmaceutical Sciences, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Antwerp 2610, Belgium.
- Department of Medical Chemistry, Faculty of Chemistry, Adam Mickiewicz University, Poznań 61-614, Poland.
- Cell Death Signaling Lab, Department of Biomedical Sciences, University of Antwerp, Antwerp 2610, Belgium.
- Infla-Med Centre of Excellence, University of Antwerp, Antwerp 2610, Belgium.
- Molecular Signalling and Cell Death Unit, VIB Center for Inflammation Research, Ghent 9052, Belgium.
- Department of Biomedical Molecular Biology, Ghent University, Ghent 9000, Belgium.
ORCID-Profile: Camilla Scarpellini, Greta Klejborowska, Karolina Musiałek, Pieter Van der Veken, Hans De Winter, Koen Augustyns
Förderung
- Universiteit Antwerpen
- H2020 Marie Sklodowska-Curie Actions
- Fonds Wetenschappelijk Onderzoek
- Fondation Charcot
Zitieren
APA
Scarpellini, C., Klejborowska, G., Lanthier, C., Toye, A., Musiałek, K., Van San, E., Walravens, M., Berg, M., Hassannia, B., Van der Veken, P., De Winter, H., Vanden Berghe, T., & Augustyns, K. (2025). Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases. Journal of Medicinal Chemistry, 68(4), 4908-4928. https://doi.org/10.1021/acs.jmedchem.4c03149
Vancouver
Scarpellini C, Klejborowska G, Lanthier C, Toye A, Musiałek K, Van San E, et al. Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases. Journal of Medicinal Chemistry. 2025;68(4):4908-4928. doi:10.1021/acs.jmedchem.4c03149
BibTeX
@article{Scarpellini2025,
author = {Scarpellini, Camilla and Klejborowska, Greta and Lanthier, Caroline and Toye, Ariane and Musiałek, Karolina and Van San, Emily and Walravens, Magali and Berg, Maya and Hassannia, Behrouz and Van der Veken, Pieter and De Winter, Hans and Vanden Berghe, Tom and Augustyns, Koen},
title = {Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {4},
pages = {4908--4928},
doi = {10.1021/acs.jmedchem.4c03149}
}
EUVIMED